Applied therapeutics: the clinical use of drugs. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009. p. 101-103. ISBN 0-7817-6555-2.
On behalf of the US preventive services task, force* (Feb 26, 2013). ‘Vitamin D and calcium supplementation to prevent fractures in adults: US preventive services task force recommendation statement’. Annals of Internal Med 2013;158: 691-696.
Osteopaenia in primary health care patients: do we need to be more rigorous? Rheumatol Clin 2009;5(1):13-17.
The effects of organic nitrates on osteoporosis: a randomized control trial Trials 2006,7:10.
Osteoporosis—an emerging disease of the 21st century: part 1—an overview. Jfmpc 2012;1(1):66-68.
Rationale for using nitric oxide donor therapy for prevention of bone loss and treatment of osteoporosis in humans. Ann NY Acad Sci 2007 Nov; 1117:283-297.
Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Bone 2003;32: 142-149.
The effects of organic nitrates on osteoporosis: a systematic review. Osteoporos Int 2013 Mar; 24(3):763-770.
Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss; a human pilot clinical study. J Bone Miner Res 2000 Nov;15(11):2240-2244.